Decipher Labs considering business expansion of portfolio to cater to retail sales of medicines

24 Dec 2020 Evaluate

Decipher Labs is considering the business expansion of its portfolio to cater to retail sales of medicines by opening and operating pharmacies and online marketing and sales globally. With the foray into the retail segment, the company envisages to achieve robust growth through high volume sales. The latest proposed expansion gels well with the business outlook of the company as it envisages to capitalize on its brand values and nationwide presence thus enabling a nationwide franchise by providing a commercially viable proposition.

The Board proposes to create a separate subsidiary company to market various formulations and other allied products including neutraceuticals, herbal and ayurvedic medications and other allied products. The company proposes to have a soft launch of its services in Hyderabad and expand to the states of South India initially and further expand across India. The company expects to cater to a vast majority of drugs for recurring and chronic ailments apart from over-the-counter products for health, wellness, and personal care and lifestyle medications including neutraceuticals, herbal and ayurvedic medications and other allied products.

The Board with a view of making the company’s global presence in the field of Pharma, is also on the lookout for strategic alliances to further expand its presence domestically and internationally. The company expects to initiate the process of obtaining requisite approvals and subject to statutory approvals, start commercial sales and expand its revenue base as early as the end this year. 

Decipher Labs Share Price

15.09 0.01 (0.07%)
23-May-2024 15:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1494.95
Dr. Reddys Lab 5882.45
Cipla 1487.45
Zydus Lifesciences 1087.65
Lupin 1631.60
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.